Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025

BUY
$58.08 - $81.05 $28,691 - $40,038
494 Added 16.77%
3,439 $237 Million
Q1 2025

Apr 11, 2025

BUY
$69.3 - $90.95 $4,019 - $5,275
58 Added 2.01%
2,945 $205 Million
Q4 2024

Feb 10, 2025

BUY
$85.0 - $120.04 $245,395 - $346,555
2,887 New
2,887 $248 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Impact Capital Partners LLC Portfolio

Follow Impact Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impact Capital Partners LLC with notifications on news.